10.1016/j.eplepsyres.2012.09.016 Epilepsy Res
Summary: GLP-1 receptor agonists are not licensed for NAFLD treatment in the UK but may reduce liver fat and improve metabolic parameters when prescribed for type 2 diabetes or weight management in eligible patients with concurrent liver disease
Patients with severe renal or hepatic impairment, active pancreatitis, or a history of diabetic ketoacidosis require close provider oversight and may not be appropriate candidates
It's really important to answer these questions truthfully and completely
Adding booze to THC makes the high stronger and can cause nausea, dizziness, or unexpected effects
Subsequently, Zhongmei Huadong fully transitioned to a biosimilar development pathway, but with clear advantages in clinical data, submission quality, and commercialization capabilities, it remains a strong competitor for the first generic drug